期刊文献+

外源性FHIT基因表达对顺铂诱导宫颈癌SiHa细胞凋亡的影响 被引量:3

Combined effects of extopic FHIT gene with cisplatin on SiHa apoptosis.
下载PDF
导出
摘要 目的:探讨外源性脆性组氨酸三联体(fragile histidine triad,FHIT)基因表达与顺铂(cisplatin,DDP)是否可协同促进宫颈癌SiHa细胞的凋亡。方法:重组质粒PRcC-MV-FHIT(A组)及空质粒PRcCMV(B组)分别转染无内源性FHIT蛋白表达的SiHa细胞(未转染SiHa细胞为C组),Western Blot检测外源性FHIT蛋白的表达,使用不同浓度的顺铂分别处理各组细胞,通过AO-EB染色、流式细胞术检测顺铂处理后各组细胞的凋亡。结果:顺铂处理48h后进行流式细胞仪检测,重组质粒+DDP2.0μg/ml、未转染细胞+DDP2.0μg/ml及未用顺铂处理的重组质粒组凋亡率分别为51.03%、20.58%、22.07%,重组质粒+DDP组细胞凋亡更明显(重组质粒+DDP2.0μg/ml组与未转染细胞+DDP2.0μg/ml及未用顺铂处理的重组质粒组相比P<0.01),AO-EB染色亦见顺铂处理的重组质粒组凋亡细胞明显增多。结论:外源性FHIT基因表达与顺铂协同促进SiHa细胞凋亡,为基因治疗与化疗联合治疗宫颈癌提供理论基础。 Objective: To investigate the effect of fragile histidine triad (FHIT) expression on the apoptosis induced by chemotherapeutics agent cisplatin (DDP). Methods: PRcCMV-FHIT and PRcCMV were transfected into cervical cancer cell line SiHa lacking fulllength FHIT transcripts and endogenous FHIT protein, the expression of extopic FHIT protein was examinated by Western blot,apoptosis were examinated by AO-EB stain and flour cell assess(FCA). Results: The apoptosis rate was respectively 51.03% ,20.58% ,22.07% in recombine plasmid + DDP2.01μg/ml group,blank cell + DDP2.0μg/ml group,recombine plasmid group,the number of apoptotic cells was also statistically increased in recombine plasmid + DDP2.01μg/ml group by AO-EB stain. Conclusion: Cisplatin-induced apoptosis can be enhanced by extopic FHIT expression in cervical cancer cell line SiHa, which provides a experimental basis for the treatment of cervix neoplasms with gene therapy combined with chemotherapy.
出处 《现代妇产科进展》 CSCD 北大核心 2006年第1期46-49,共4页 Progress in Obstetrics and Gynecology
关键词 宫颈肿瘤 基因 FHIT 转染 顺铂 细胞凋亡 Cervix neoplasms Genes, FHIT Transfection Cisplatin Apoptosis
  • 相关文献

参考文献1

二级参考文献36

  • 1Sorio C, Baron A, Orlandini S, Zamboni G, Pederzoli P,Huebner K, Scarpa A. The FHIT gene is expressed in pancreatic ductular ceils and is altered in pancreatic cancers. Cancer Res 1999; 59:1308-1314.
  • 2Hadaczek P, Siprashvili Z, Markiewski M, Domagala W,Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K, Lubinski J. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res 1998; 58:2946-2951.
  • 3Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schroder JK, Bardenheuer W, Seeber S, Huebner K, Schutte J, Opalka B.Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. Cancer Res 2000; 60:2780-2785.
  • 4Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT,Kim YT, Mok JE, Munoz N, Bosch FX, Shah K, Cho KR. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 1997; 57:4692-4698.
  • 5Yoshino K, Enomoto T, Nakamura T, Nakashima R, Wada H, Saitoh J, Noda K, Murata Y. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer 1998; 76:176-181.
  • 6Birrer MJ, Hendricks D, Farley J, Sundborg MJ, Bonome T,Waits MJ, Geradts J. Abnormal Fhit expression in malignant and premalignant lesions of the cervix. Cancer Res 1999; 59:5270-5274.
  • 7Wu R, Connolly DC, Dunn RL, Cho KR. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma ceils. J Natl Cancer Inst 2000; 92:338-344.
  • 8Chen YJ, Chen PH, Chang JG. Aberrant FHIT transcripts in hepatocellular carcinomas. Br J Cancer 1998; 77:417-420.
  • 9Schlott T, Ahrens K, Ruschenburg I, Reimer S, Hartmann H,Droese M. Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hvperplasia. Br J Cancer 1999; 80:73-78.
  • 10Keck CL, Zimonjic DB, Yuan BZ, Thorgeirsson SS, Popescu NC. Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines.Cancer Genet Cytogenet 1999; 111:37-44.

共引文献29

同被引文献60

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部